MARK M. MULLALLY

5-N-Acetylardeemin, a novel heterocyclic compound which reverses multiple drug resistance in tumor cells. II. Isolation and elucidation of the structure of 5-N-acetylardeemin and two congeners.

Jill E. Hochlowski, MARK M. MULLALLY, Stephen G. Spanton et al. · The Journal of Antibiotics · 1993 · 101 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-<i>N</i>-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Jeffrey J. Rohde, Marina Pliushchev, Bryan K. Sorensen et al. · Journal of Medicinal Chemistry · 2006 · 77 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

MLR-52,(4'-dementhylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity.

J. B. MCALPINE, James P. Karwowski, MARIANNA JACKSON et al. · The Journal of Antibiotics · 1994 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Macquarimicins, Microbial Metabolites from Micromonospora. II. Isolation and Structural Elucidation.

Jill E. Hochlowski, MARK M. MULLALLY, Rodger F. Henry et al. · The Journal of Antibiotics · 1995 · 25 citations · Full text

Life Sciences, Biochemistry, Microbiology +10

Dunaimycins, a new complex of spiroketal 24-membered macrolides with immunosuppressive activity. II. Isolation and elucidation of structures.

Jill E. Hochlowski, MARK M. MULLALLY, GREGORY M. BRILL et al. · The Journal of Antibiotics · 1991 · 23 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12